Medical debutant, BYD worth a look

Newly listed Suzhou Basecare Medical (2170) and BYD (1211) have caught the eye of investment expert Dr Check.

Suzhou Basecare Medical, which went public just two weeks ago, was oversubscribed 400 times for its initial public offering but the genetic testing solution provider’s share price went up by only 1.2 percent on its market debut from the IPO price of HK$27.36, Dr Check points out in a video on The Standard’s website and Facebook page.

Its shares have suddenly risen above HK$32 after hovering around its IPO price for five days, which may suggest the stock has been cornered and can be driven up, Dr Check says.

Dr Check says BYD has been trading between HK$235 to HK$270 and is undergoing a correction.

He aexpects the carmaker’s shares to test the 50-day moving average. He also expects the short video platform Kuaishou (1024) to rise in the short term.